Home / People / Dex Destombes
Portrait of Dex Destombes

Dex Destombes


Atrium - Parnassusweg 737
1077 DG Amsterdam
PO Box 94700
1090 GS Amsterdam
Languages Dutch, English

Dex Destombes is a member of our firm's Corporate/M&A Practice Group. He specialises in corporate and securities law. Dex advises inter alia on transactions at both national and international level.​

Clients are mostly international and domestic investment firms, insurance companies and corporates.

more less


  • Master Dutch Law (Commercial Law Practice), University of Amsterdam
more less


CMS ad­vised Korys In­vest­ments on its Series B in­vest­ment round of € 15...
CMS ad­vised Korys In­vest­ments N.V. on its par­ti­cip­a­tion in a EUR 15 mil­lion Series B in­vest­ment round re­gard­ing Trunkrs B.V.Korys In­vest­ments N.V. is the in­vest­ment firm of the Col­ruyt fam­ily. Korys is...
CMS ad­vised Ri­eter on the ac­quis­i­tion of three busi­nesses from Saur­er
CMS has ad­vised Ri­eter Hold­ing AG in con­nec­tion with its ac­quis­i­tion of 57% of the shares in the cap­it­al of Saur­er Neth­er­lands Ma­chinery Com­pany B.V. The trans­ac­tion value amounts to EUR 300 mil­lion...
CMS Ad­vises Frasers In­dus­tri­al & Com­mer­cial Trust on in­terest in FPE
CMS has ad­vised Frasers In­dus­tri­al & Com­mer­cial Trust on the ac­quis­i­tion of an in­terest in FPE In­vest­ments RE5 B.V, FPE In­vest­ments RE6 B.V., FPE In­vest­ments RE10 B.V. and Frankenth­al S.A. from its spon­sor...
CMS ad­vises Im­mat­ics on the busi­ness com­bin­a­tion with Arya Sci­ences Ac­quis­i­tion...
Im­mat­ics N.V. has an­nounced the com­ple­tion of its busi­ness com­bin­a­tion with Arya Sci­ences Ac­quis­i­tion Cor­por­a­tion. The Im­mat­ics shares and war­rants are now traded un­der the sym­bol “IMTX” and the...
CMS acts on the sale of fu­ner­al in­sur­ance com­pany Nuvema
CMS has ac­ted for Con­ser­vat­rix Groep S.à.r.l. on the sale of N.V. Neder­landse Uitvaart Verzeker­ing Maatschap­pij (Nuvema) to Lifetri Group. Nuvema is a fu­ner­al in­sur­ance com­pany with ap­prox­im­ately 185.000...
CMS ad­vises Ad­vance on Stage En­ter­tain­ment Ac­quis­i­tion
CMS has ad­vised Ad­vance/Ne­w­house Part­ner­ship (“Ad­vance”), a di­ver­si­fied, fam­ily-owned com­pany that op­er­ates and in­vests in a broad range of me­dia, com­mu­nic­a­tions and tech­no­logy busi­nesses, on its...
CMS acts for Cott Cor­por­a­tion on sale of bot­tling busi­ness to Re­fresco
CMS has ac­ted for Cott Cor­por­a­tion on the sale of its bot­tling activ­it­ies for non-al­co­hol­ic bever­ages to Re­fresco Hold­ing N.V. for a pur­chase price of USD 1.25 bil­lion. The trans­ac­tion is sub­ject to ap­prov­al...